Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-09

Clinical Trial Update: Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers [NA]

View source ↗

Summary

This clinical trial update discusses the potential use of cytarabine in Acute Myeloid Leukemia and explores whether constitutional biomarkers can guide therapeu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTARABINE (CYTARABINE)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Acute Myeloid Leukemia | NA | Status: UNKNOWN